文献速递心脑血管急症重症综合管理与镇静镇痛

血管内取栓术后血压下降与功能结局的关系

Functional Outcomes Associated With Blood Pressure Decrease After Endovascular Thrombectomy.
PubMed 文献 · JAMA Netw Open · 2024-04-01
一句话结论成功再通后24小时内药物诱导收缩压降至100 mm Hg以下与3个月功能独立率更低、死亡率更高相关,作者认为可能有害。

该研究为血管内取栓-最佳血压控制试验的事后分析,纳入2020年6月18日至2022年11月28日韩国19家卒中中心302例成功再通且再通后2小时内血压升高的取栓患者。血压下降定义为至少1次收缩压<100 mm Hg,分为药物诱导血压下降组47例(15.6%)、自发血压下降组39例(12.9%)和无血压下降组216例(71.5%)。校正混杂后,药物诱导组3个月功能独立比例显著低于无血压下降组(AOR 0.45;95%CI 0.20-0.98),3个月死亡 odds 更高(AOR 5.15;95%CI 1.42-19.4);自发下降组与无下降组功能独立无显著差异(AOR 1.41;95%CI 0.58-3.49)。症状性颅内出血各组无显著差异。作者认为用降压药将收缩压降至100 mm Hg以下可能有害。

要点

  • 成功再通后24小时内药物诱导收缩压<100 mm Hg者3个月功能独立比例显著低于无血压下降者(AOR 0.45;95%CI 0.20-0.98)。
  • 药物诱导血压下降组3个月死亡风险显著高于无血压下降组(AOR 5.15;95%CI 1.42-19.4)。
  • 自发血压下降组与无血压下降组3个月功能独立无显著差异(AOR 1.41;95%CI 0.58-3.49)。
  • 症状性颅内出血各组间无显著差异(药物诱导 vs 无下降:AOR 1.89;95%CI 0.54-5.88;自发下降 vs 无下降:AOR 2.75;95%CI 0.76-9.46)。
  • 作者认为,使用降压药将收缩压降至100 mm Hg以下可能有害。

适用人群与场景

  • 2020年6月18日至2022年11月28日韩国19家卒中中心接受血管内取栓、成功再通且再通后2小时内血压升高的302例患者。

诊断标准与关键阈值

  • 血压下降定义为至少1次收缩压<100 mm Hg。
  • 按血压下降原因分为药物诱导血压下降组、自发血压下降组和无血压下降组。

研究设计与关键结果

  • 研究类型为血管内取栓-最佳血压控制试验的事后队列分析,纳入302例患者,中位年龄75岁(IQR 66-82),男性180例(59.6%)。
  • 药物诱导血压下降组47例(15.6%),自发血压下降组39例(12.9%),无血压下降组216例(71.5%)。
  • 主要结局:3个月功能独立(改良Rankin量表评分0-2分);药物诱导组比例显著低于无血压下降组(AOR 0.45;95%CI 0.20-0.98);自发下降组与无下降组无显著差异(AOR 1.41;95%CI 0.58-3.49)。
  • 安全性结局:药物诱导组3个月死亡 odds 显著高于无血压下降组(AOR 5.15;95%CI 1.42-19.4)。
  • 症状性颅内出血发生率各组无显著差异(药物诱导 vs 无下降:AOR 1.89;95%CI 0.54-5.88;自发下降 vs 无下降:AOR 2.75;95%CI 0.76-9.46)。

证据类型、等级与局限

  • 证据类型:队列研究(血管内取栓-最佳血压控制试验的事后分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,成功再通后24小时内使用降压药将收缩压降至100 mm Hg以下可能有害。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The associations between blood pressure (BP) decreases induced by medication and functional outcomes in patients with successful endovascular thrombectomy remain uncertain.

OBJECTIVE: To evaluate whether BP reductions induced by intravenous BP medications are associated with poor functional outcomes at 3 months.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a post hoc analysis of the Outcome in Patients Treated With Intra-Arterial Thrombectomy-Optimal Blood Pressure Control trial, a comparison of intensive and conventional BP management during the 24 hours after successful recanalization from June 18, 2020, to November 28, 2022. This study included 302 patients who underwent endovascular thrombectomy, achieved successful recanalization, and exhibited elevated BP within 2 hours of successful recanalization at 19 stroke centers in South Korea.

EXPOSURE: A BP decrease was defined as at least 1 event of systolic BP less than 100 mm Hg. Patients were divided into medication-induced BP decrease (MIBD), spontaneous BP decrease (SpBD), and no BP decrease (NoBD) groups.

MAIN OUTCOMES AND MEASURES: The primary outcome was a modified Rankin scale score of 0 to 2 at 3 months, indicating functional independence. Primary safety outcomes were symptomatic intracerebral hemorrhage within 36 hours and mortality due to index stroke within 3 months.

RESULTS: Of the 302 patients (median [IQR] age, 75 [66-82] years; 180 [59.6%] men), 47 (15.6%)were in the MIBD group, 39 (12.9%) were in the SpBD group, and 216 (71.5%) were in the NoBD group. After adjustment for confounders, the MIBD group exhibited a significantly smaller proportion of patients with functional independence at 3 months compared with the NoBD group (adjusted odds ratio [AOR], 0.45; 95% CI, 0.20-0.98). There was no significant difference in functional independence between the SpBD and NoBD groups (AOR, 1.41; 95% CI, 0.58-3.49). Compared with the NoBD group, the MIBD group demonstrated higher odds of mortality within 3 months (AOR, 5.15; 95% CI, 1.42-19.4). The incidence of symptomatic intracerebral hemorrhage was not significantly different among the groups (MIBD vs NoBD: AOR, 1.89; 95% CI, 0.54-5.88; SpBD vs NoBD: AOR, 2.75; 95% CI, 0.76-9.46).

CONCLUSIONS AND RELEVANCE: In this cohort study of patients with successful endovascular thrombectomy after stroke, MIBD within 24 hours after successful recanalization was associated with poor outcomes at 3 months. These findings suggested lowering systolic BP to below 100 mm Hg using BP medication might be harmful.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Jung JW, Kim KH, Yun J, et al. Functional Outcomes Associated With Blood Pressure Decrease After Endovascular Thrombectomy. JAMA Netw Open. 2024. PMID: 38630474. doi:10.1001/jamanetworkopen.2024.6878

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。